Interpretation of the Japanese 2015 guidelines for vascular access: establishment of difficult vascular access and treatment strategies for its complications

doi:10.3877/cma.j.issn.2095-3216.2018.05.009

Abstract

Abstract:

With the increases of patient survival rate, aging, chronic disease and diabetic nephropathy, the depletion of vascular access is becoming more common, and the establishment and repair of vascular access are becoming more and more difficult. The establishment of vascular access, graft vascular access, and superficial arterial puncture as well as the prevention and treatment strategies of complications will become important factors affecting the level of hemodialysis. This article provided an overview of the arteriovenous grafts (AVG) access, the establishment of arteries superficialization, and perioperative management according to the Japanese 2015 guidelines for vascular access.

Key words: Difficult vascular access, Complications, Graft vascular access, Arterial superficial puncture

Jiawei Liu, Rong Wang, Xing Wu, Gang Wu. Interpretation of the Japanese 2015 guidelines for vascular access: establishment of difficult vascular access and treatment strategies for its complications[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2018, 07(05): 231-233.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2018.05.009

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2018/V07/I05/231

Figures/Tables 2

References 23

[1]	Kukita K, Ohira S, Amano I, et al. 2011 update Japanese Society for Dialysis Therapy guidelines of vascular access construction and repair for chronic hemodialysis [J]. Ther Apher Dial, 2015, 19 (Suppl 1): 1-39.
[2]	Akoh J. Prosthetic arteriovenous grafts for hemodialysis [J]. J Vasc Access, 2009, 10(3): 137-147.
[3]	Kherlakian GM, Roedersheimer LR, Arbaugh JJ, et al. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis [J]. Am J Surg, 1986, 152(2): 238-243.
[4]	Ota K, Tsuji Y, Kukita K. Long-term outcome of Terumo vascular graft (GRASIL^®) for hemodialysis [J]. J Jpn Soc Dial Ther, 2006, 39: 1395-1401.
[5]	Dixon BS, Beck GJ, Vazquez MA, et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency [J]. N Engl J Med, 2009, 360(21): 2191-2201.
[6]	Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts [J]. Surgery, 1985, 97(2): 194-204.
[7]	Gargiulo NR, Veith FJ, Scher LA, et al. Experience with covered stents for the management of hemodialysis polytetrafluoroethylene graft seromas [J]. J Vasc Surg, 2008, 48(1): 216-217.
[8]	Dauria DM, Dyk P, Garvin P. Incidence and management of seroma after arteriovenous graft placement [J]. J Am Coll Surg, 2006, 203(4): 506-511.
[9]	Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: incidence, risk factors, and prognosis [J]. Kidney Int, 1999, 55(3): 1081-1090.
[10]	Amano I, Ohira S, Goto Y, et al. In preparation for a treatment guideline for suitable vascular access repair in Japan [J]. Ther Apher Dial, 2006, 10(4): 364-371.
[11]	D′Cunha PT, Besarab A. Vascular access for hemodialysis: 2004 and beyond [J]. Curr Opin Nephrol Hypertens, 2004, 13(6): 623-629.
[12]	Glickman M, Stokes G, Ross J. Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications [J]. J Vasc Surg, 2001, 34(3): 465-473.
[13]	Sakka SG, Reinhart K, Wegscheider K, et al. Comparison of cardiac output and circulatory blood volumes by transpulmonary thermo-dye dilution and transcutaneous indocyanine green measurement in critically ill patients [J]. Chest, 2002, 121(2): 559-565.
[14]	Earley A, Persson R, Raman G. III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000 [J]. Am J Kidney Dis, 2001, 37(1 Suppl 1): S137-S181.
[15]	Turmel-Rodrigues L, Pengloan J, Blanchier D. Insufficient dialysis shunts: improved long term patency rates with close hemodynamic monitering, repeated percutaneous balloon angioplasty, and stent placement [J]. Radiology, 1993, 187: 273-278.
[16]	Degawa H, Tagawa H, Tomikawa S. Long-term outcome of expanded polytetrafluoroethylene graft for hemodialysis access [J]. J Jpn Soc Dial Ther, 1995, 28: 1359-1365.
[17]	Bhatia DS, Money SR, Ochsner JL, et al. Comparison of surgical bypass and percutaneous balloon dilatation with primary stent placement in the treatment of central venous obstruction in the dialysis patient: one-year follow-up [J]. Ann Vasc Surg, 1996, 10(5): 452-455.
[18]	Kovalik EC, Newman GE, Suhocki P, et al. Correction of central venous stenoses: use of angioplasty and vascular Wallstents [J]. Kidney Int, 1994, 45(4): 1177-1181.
[19]	Poulain F, Raynaud A, Bourquelot P, et al. Local thrombolysis and thromboaspiration in the treatment of acutely thrombosed arteriovenous hemodialysis fistulas [J]. Cardiovasc Intervent Radiol, 1991, 14(2): 98-101.
[20]	Gmelin E, Winterhoff R, Rinast E. Insufficient hemodialysis access fistulas: late results of treatment with percutaneous balloon angioplasty [J]. Radiology, 1989, 171(3): 657-660.
[21]	Trerotola SO, Davidson DD, Filo RS, et al. Preclinical in vivo testing of a rotational mechanical thrombolytic device [J]. J Vasc Interv Radiol, 1996, 7(5): 717-723.
[22]	Ohira S, Naito H, Amano I, et al. 2005 Japanese Society for Dialysis Therapy guidelines for vascular access construction and repair for chronic hemodialysis [J]. Ther Apher Dial, 2006, 10(5): 449-462.
[23]	National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative. Clinical practice guidelines for vascular access [J]. Am J Kidney Dis, 1997, 30(4 Suppl 3): S150-S191.

Please choose a citation manager

Content to export